205 related articles for article (PubMed ID: 32716648)
1. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options.
Asghari A; Naseri M; Safari H; Saboory E; Parsamanesh N
DNA Cell Biol; 2020 Oct; 39(10):1741-1753. PubMed ID: 32716648
[TBL] [Abstract][Full Text] [Related]
2. Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.
Muchtaridi M; Fauzi M; Khairul Ikram NK; Mohd Gazzali A; Wahab HA
Molecules; 2020 Sep; 25(17):. PubMed ID: 32882868
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus Disease 2019-COVID-19.
Dhama K; Khan S; Tiwari R; Sircar S; Bhat S; Malik YS; Singh KP; Chaicumpa W; Bonilla-Aldana DK; Rodriguez-Morales AJ
Clin Microbiol Rev; 2020 Sep; 33(4):. PubMed ID: 32580969
[TBL] [Abstract][Full Text] [Related]
4. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
Choudhary S; Malik YS; Tomar S
Front Immunol; 2020; 11():1664. PubMed ID: 32754161
[TBL] [Abstract][Full Text] [Related]
5. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
6. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
[TBL] [Abstract][Full Text] [Related]
7. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).
Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF
Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085
[TBL] [Abstract][Full Text] [Related]
8. A global treatments for coronaviruses including COVID-19.
Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
[TBL] [Abstract][Full Text] [Related]
9. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
Blaess M; Kaiser L; Sauer M; Csuk R; Deigner HP
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668803
[TBL] [Abstract][Full Text] [Related]
10. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
Erensoy S
Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 (COVID-19) by the numbers.
Bar-On YM; Flamholz A; Phillips R; Milo R
Elife; 2020 Apr; 9():. PubMed ID: 32228860
[TBL] [Abstract][Full Text] [Related]
12. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated
Chan JF; Yip CC; To KK; Tang TH; Wong SC; Leung KH; Fung AY; Ng AC; Zou Z; Tsoi HW; Choi GK; Tam AR; Cheng VC; Chan KH; Tsang OT; Yuen KY
J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32132196
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 RNA polymerase as target for antiviral therapy.
Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758
[TBL] [Abstract][Full Text] [Related]
14. Corona virus versus existence of human on the earth: A computational and biophysical approach.
Zehra Z; Luthra M; Siddiqui SM; Shamsi A; Gaur NA; Islam A
Int J Biol Macromol; 2020 Oct; 161():271-281. PubMed ID: 32512089
[TBL] [Abstract][Full Text] [Related]
15. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
16. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
17. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
Greene DN
J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
[TBL] [Abstract][Full Text] [Related]
18. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
19. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
[TBL] [Abstract][Full Text] [Related]
20. [Overview of novel coronavirus infection and replication].
He L; Liu W; Li J
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1961-1969. PubMed ID: 33169562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]